These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1697319)
21. Membrane lymphotoxin is required for resistance to Theiler's virus infection. Lin X; Ma X; Rodriguez M; Feng X; Zoecklein L; Fu YX; Roos RP Int Immunol; 2003 Aug; 15(8):955-62. PubMed ID: 12882833 [TBL] [Abstract][Full Text] [Related]
22. Improvement in sensitivity of enzyme-linked immunosorbent assay for tumour necrosis factor. McLaughlin PJ; Elwood NJ; Ramadi LT; Pica MR; McKenzie IF Immunol Cell Biol; 1990 Feb; 68 ( Pt 1)():51-5. PubMed ID: 2318511 [TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease. Kretschmer C; Jones DB; Morrison K; Schlüter C; Feist W; Ulmer AJ; Arnoldi J; Matthes J; Diamantstein T; Flad HD Am J Pathol; 1990 Aug; 137(2):341-51. PubMed ID: 2386200 [TBL] [Abstract][Full Text] [Related]
24. Commercially available antibodies to human tumour necrosis factor-alpha tested for cross-reactivity with ovine and bovine tumour necrosis factor-alpha using flow cytometric assays. Dernfalk J; Waller KP; Johannisson A Acta Vet Scand; 2004; 45(1-2):99-107. PubMed ID: 15535090 [TBL] [Abstract][Full Text] [Related]
25. Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab Assays. Van Stappen T; Brouwers E; Tops S; Geukens N; Vermeire S; Declerck PJ; Gils A Ther Drug Monit; 2015 Aug; 37(4):479-85. PubMed ID: 25525757 [TBL] [Abstract][Full Text] [Related]
26. Simple enzyme immunoassay methods for recombinant human tumor necrosis factor alpha and its antibodies using a bacterial cell wall carrier. Sunahara N; Kurooka S; Kaibe K; Ohkaru Y; Nishimura S; Nakano K; Sohmura Y; Iida M J Immunol Methods; 1988 May; 109(2):203-14. PubMed ID: 3283246 [TBL] [Abstract][Full Text] [Related]
27. Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. van der Meer JW; Endres S; Lonnemann G; Cannon JG; Ikejima T; Okusawa S; Gelfand JA; Dinarello CA J Leukoc Biol; 1988 Mar; 43(3):216-23. PubMed ID: 3257788 [TBL] [Abstract][Full Text] [Related]
28. Mode of interaction between tumor necrosis factor alpha and a monoclonal antibody expressing a recurrent idiotype. Barbanti E; Corti A; Ghislieri M; Casero D; Rifaldi B; Portello C; Breme U; Trizio D; Marcucci F Hybridoma; 1993 Feb; 12(1):1-13. PubMed ID: 8454296 [TBL] [Abstract][Full Text] [Related]
29. Cytolytic activity of Ia-restricted T cell clones and hybridomas: evidence for a cytolytic mechanism independent of interferon-gamma, lymphotoxin, and tumor necrosis factor-alpha. Ju ST; Strack P; Stromquist D; Dekruyff RH Cell Immunol; 1988 Dec; 117(2):399-413. PubMed ID: 2973845 [TBL] [Abstract][Full Text] [Related]
30. Humanization of a mouse monoclonal antibody neutralizing TNF-alpha by guided selection. Wang Z; Wang Y; Li Z; Li J; Dong Z J Immunol Methods; 2000 Jul; 241(1-2):171-84. PubMed ID: 10915859 [TBL] [Abstract][Full Text] [Related]
31. Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats. Corcoran AE; Barrett K; Turner M; Brown A; Kissonerghis AM; Gadnell M; Gray PW; Chernajovsky Y; Feldmann M Eur J Biochem; 1994 Aug; 223(3):831-40. PubMed ID: 8055960 [TBL] [Abstract][Full Text] [Related]
32. Properties of monoclonal antibodies to human tumor necrosis factor alpha (TNF alpha). McLaughlin PJ; Elwood NJ; Russell SM; Andrew SM; McKenzie IF Anticancer Res; 1992; 12(4):1243-6. PubMed ID: 1503416 [TBL] [Abstract][Full Text] [Related]
33. Porcine hematopoiesis on primate stroma in long-term cultures: enhanced growth with neutralizing tumor necrosis factor-alpha and tumor growth factor-beta antibodies. Giovino MA; Down JD; Jackson JD; Sykes M; Monroy RL; White-Scharf ME Transplantation; 2002 Mar; 73(5):723-31. PubMed ID: 11907417 [TBL] [Abstract][Full Text] [Related]
34. Ultrasensitive multiplexed chemiluminescent enzyme-linked immunosorbent assays in 384-well plates. Chen T; Ubaidu A; Douglas S; Carranza S; Wong A; Kan CW; Duffy DC J Immunol Methods; 2022 Sep; 508():113311. PubMed ID: 35787394 [TBL] [Abstract][Full Text] [Related]
35. Production and characterization of monoclonal antibodies to human tumor necrosis factor. Hirai M; Okamura N; Terano Y; Tsujimoto M; Nakazato H J Immunol Methods; 1987 Jan; 96(1):57-62. PubMed ID: 3805735 [TBL] [Abstract][Full Text] [Related]
36. Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy. Grom AA; Murray KJ; Luyrink L; Emery H; Passo MH; Glass DN; Bowlin T; Edwards C Arthritis Rheum; 1996 Oct; 39(10):1703-10. PubMed ID: 8843861 [TBL] [Abstract][Full Text] [Related]
37. TNF production and hypertrophic scarring. Castagnoli C; Stella M; Berthod C; Magliacani G; Richiardi PM Cell Immunol; 1993 Mar; 147(1):51-63. PubMed ID: 8462114 [TBL] [Abstract][Full Text] [Related]
38. A novel monoclonal human IgM autoantibody which binds recombinant human and mouse tumor necrosis factor-alpha. Boyle P; Lembach KJ; Wetzel GD Cell Immunol; 1993 Dec; 152(2):556-68. PubMed ID: 7504981 [TBL] [Abstract][Full Text] [Related]
39. Lymphotoxin alpha and tumour necrosis factor are not required for control of parasite growth, but differentially regulate cytokine production during Plasmodium chabaudi chabaudi AS infection. Clark K; Kulk N; Amante F; Haque A; Engwerda C Parasite Immunol; 2007 Mar; 29(3):153-8. PubMed ID: 17266742 [TBL] [Abstract][Full Text] [Related]
40. Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity. Körner H; Sedgwick JD Immunol Cell Biol; 1996 Oct; 74(5):465-72. PubMed ID: 8912010 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]